Evolution of Haematopoietic Cell Transplantation for Canine Blood Disorders and a Platform for Solid Organ Transplantation

Overview

Journal Vet Med Sci

Specialty Veterinary Medicine

Date 2021 Aug 14

PMID 34390541

Citations 2

Authors

Scott S Graves

Rainer Storb

Affiliations

Soon will be listed here.

Abstract

Pre-clinical haematopoietic cell transplantation (HCT) studies in canines have proven to be invaluable for establishing HCT as a highly successful clinical option for the treatment of malignant and non-malignant haematological diseases in humans. Additionally, studies in canines have shown that immune tolerance, established following HCT, enabled transplantation of solid organs without the need of lifelong immunosuppression. This progress has been possible due to multiple biological similarities between dog and mankind. In this review, the hurdles that were overcome and the methods that were developed in the dog HCT model which made HCT clinically possible are examined. The results of these studies justify the question whether HCT can be used in the veterinary clinical practice for more wide-spread successful treatment of canine haematologic and non-haematologic disorders and whether it is prudent to do so.

Citing Articles

What We Know and Do Not Yet Know About the Canine Model of Lymphoma in Human Medicine-The Current State of Knowledge.

Bedkowska D, Al-Ameri S, Wieczorek A, Bubak J, Miszczak M Cancers (Basel). 2025; 17(4).

PMID: 40002191 PMC: 11853190. DOI: 10.3390/cancers17040596.

Stem Cell-Based Disease Models for Inborn Errors of Immunity.

Zbinden A, Cante-Barrett K, Pike-Overzet K, Staal F Cells. 2022; 11(1).

PMID: 35011669 PMC: 8750661. DOI: 10.3390/cells11010108.

Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation.

Graves S, Storb R Vet Med Sci. 2021; 7(6):2156-2171.

PMID: 34390541 PMC: 8604109. DOI: 10.1002/vms3.601.

References

Chang J, Graves S, Butts-Miwongtum T, Sale G, Storb R, Mathes D . Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells. Transplantation. 2016; 100(12):e120-e127. PMC: 5453180. DOI: 10.1097/TP.0000000000001496. View

Graves S, Parker M, Stone D, Sale G, Pillai S, Johnson M . Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2017; 24(1):50-54. PMC: 5743626. DOI: 10.1016/j.bbmt.2017.09.010. View

Rosinski S, Storb R, Strong R, Sale G, Stone D, Gewe M . Anti-CD28 Antibody-Initiated Cytokine Storm in Canines. Transplant Direct. 2015; 1(2). PMC: 4433175. DOI: 10.1097/TXD.0000000000000516. View

Zaucha J, Yu C, Zellmer E, Takatu A, Junghanss C, Little M . Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation.... Biol Blood Marrow Transplant. 2001; 7(9):513-6. DOI: 10.1053/bbmt.2001.v7.pm11669218. View

Tang J, Le S, Sun L, Yan X, Zhang M, MacLeod J . Copy number abnormalities in sporadic canine colorectal cancers. Genome Res. 2010; 20(3):341-50. PMC: 2840980. DOI: 10.1101/gr.092726.109. View

Gibbs D, Spellacy E, Tompkins R, Watts R, Mowbray J . A clinical trial of fibroblast transplantation for the treatment of mucopolysaccharidoses. J Inherit Metab Dis. 1983; 6(2):62-81. DOI: 10.1007/BF02338973. View

Takatu A, Nash R, Zaucha J, Little M, Georges G, Sale G . Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia. Biol Blood Marrow Transplant. 2003; 9(11):674-82. DOI: 10.1016/j.bbmt.2003.08.005. View

Esensten J, Helou Y, Chopra G, Weiss A, Bluestone J . CD28 Costimulation: From Mechanism to Therapy. Immunity. 2016; 44(5):973-88. PMC: 4932896. DOI: 10.1016/j.immuni.2016.04.020. View

EPSTEIN R, Storb R, RAGDE H, Thomas E . Cytotoxic typing antisera for marrow grafting in littermate dogs. Transplantation. 1968; 6(1):45-58. DOI: 10.1097/00007890-196801000-00005. View

10.

Goldschmidt M, Kennedy J, Kennedy D, Yuan H, Holt D, Casal M . Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs. J Virol. 2006; 80(13):6621-8. PMC: 1488951. DOI: 10.1128/JVI.02571-05. View

11.

Shosu K, Sakurai M, Inoue K, Nakagawa T, Sakai H, Morimoto M . Programmed Cell Death Ligand 1 Expression in Canine Cancer. In Vivo. 2016; 30(3):195-204. View

12.

Yeager A, Singer H, Buck J, Matalon R, Brennan S, OToole S . A therapeutic trial of amniotic epithelial cell implantation in patients with lysosomal storage diseases. Am J Med Genet. 1985; 22(2):347-55. DOI: 10.1002/ajmg.1320220219. View

13.

Schaefer S, Werner J, Lange S, Machka C, Knuebel G, Sekora A . Graft-versus-Host Disease in a Dog After Reduced-intensity Hematopoietic Stem Cell Transplantation from a DLA-identical Littermate. In Vivo. 2016; 30(4):427-32. View

14.

Frimberger A, Moore A, Rassnick K, Cotter S, OSullivan J, Quesenberry P . A combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine lymphoma. J Vet Intern Med. 2006; 20(2):355-64. DOI: 10.1892/0891-6640(2006)20[355:accpwd]2.0.co;2. View

15.

Mielcarek M, Georges G, Storb R . Denileukin diftitox as prophylaxis against graft-versus-host disease in the canine hematopoietic cell transplantation model. Biol Blood Marrow Transplant. 2006; 12(9):899-904. DOI: 10.1016/j.bbmt.2006.05.005. View

16.

Yunusov M, Kuhr C, Georges G, Sale G, Spector M, Lesnikova M . Survival of small bowel transplants in canine mixed hematopoietic chimeras: preliminary results. Transplant Proc. 2002; 34(8):3366-7. DOI: 10.1016/s0041-1345(02)03614-x. View

17.

Fefer A . Adoptive tumor immunotherapy in mice as an adjunct to whole-body x-irradiation and chemotherapy. A review. Isr J Med Sci. 1973; 9(3):350-65. View

18.

Kijas J, Bauer Jr T, Gafvert S, Marklund S, Trowald-Wigh G, Johannisson A . A missense mutation in the beta-2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency. Genomics. 1999; 61(1):101-7. DOI: 10.1006/geno.1999.5948. View

19.

Sachs D, Sykes M, Kawai T, Cosimi A . Immuno-intervention for the induction of transplantation tolerance through mixed chimerism. Semin Immunol. 2011; 23(3):165-73. PMC: 3178004. DOI: 10.1016/j.smim.2011.07.001. View

20.

Nishida T, Hudecek M, Kostic A, Bleakley M, Warren E, Maloney D . Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia. Clin Cancer Res. 2009; 15(14):4759-68. PMC: 2785487. DOI: 10.1158/1078-0432.CCR-09-0199. View